Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (INX-315-01)
NCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardACTRN 12624000478516 Brief Summary This study aims to assess the safety and…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forwardNCT 05037760 Brief Summary This is a Phase 2, multicenter, open-label study…
Read more arrow_forwardNCT 04581512 Brief Summary A research study looking at a new treatment…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this study…
Read more arrow_forwardACTRN 12625000160437 Brief Summary This study aims to evaluate the feasibility and…
Read more arrow_forward